These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 6890637)
21. The dopamine-gamma aminobutyric acid interaction in the striatum of the rat is differently regulated by dopamine D-1 and D-2 types of receptor: evidence obtained with rotational behavioural experiments. Herrera-Marschitz M; Ungerstedt U Acta Physiol Scand; 1987 Mar; 129(3):371-80. PubMed ID: 3033996 [TBL] [Abstract][Full Text] [Related]
22. Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity. Obuchowicz E; Krysiak R; Wieronska JM; Smialowska M; Herman ZS Neuropeptides; 2005 Oct; 39(5):515-23. PubMed ID: 16154634 [TBL] [Abstract][Full Text] [Related]
23. Differential effect of acute and chronic haloperidol administration on dopamine turnover in rat nigrostriatal and retinal dopaminergic neurons. Melamed E; Durst R; Frucht Y; Globus M Eur J Pharmacol; 1983 May; 89(3-4):279-82. PubMed ID: 6873163 [TBL] [Abstract][Full Text] [Related]
24. Alterations in dopamine metabolism after chronic administration of haloperidol. Possible role of increased autoreceptor sensitivity. Saller CF; Salama AI Neuropharmacology; 1985 Feb; 24(2):123-9. PubMed ID: 3990917 [TBL] [Abstract][Full Text] [Related]
25. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum. Meller E; Friedman E Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921 [TBL] [Abstract][Full Text] [Related]
26. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol. Seeger TF; Thal L; Gardner EL Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029 [TBL] [Abstract][Full Text] [Related]
27. Behavioural responsiveness to muscimol and apomorphine 2 months after prolonged treatment with estradiol in rats. Cuomo V; Cagiano R; Apud J; Masotto C; Racagni G Psychopharmacology (Berl); 1984; 84(2):287-8. PubMed ID: 6438692 [TBL] [Abstract][Full Text] [Related]
28. In vivo release of endogenous gamma-aminobutyric acid from rat striatum: effects of muscimol, oxotremorine, and morphine. van der Heyden JA; Venema K; Korf J J Neurochem; 1980 Jun; 34(6):1648-53. PubMed ID: 7381491 [No Abstract] [Full Text] [Related]
29. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine. Agut J; Coviella IL; Wurtman RJ Neuropharmacology; 1984 Dec; 23(12A):1403-6. PubMed ID: 6543245 [TBL] [Abstract][Full Text] [Related]
30. Prevention by (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Andersen HL; Kilpatrick IC Br J Pharmacol; 1996 May; 118(2):421-7. PubMed ID: 8735647 [TBL] [Abstract][Full Text] [Related]
31. Effects of the GABA receptor agonist muscimol on the turnover of brain dopamine and on the motor activity of rats. Andén NE; Grabowska-Andén M; Wachtel H Acta Pharmacol Toxicol (Copenh); 1979 Mar; 44(3):191-6. PubMed ID: 433609 [TBL] [Abstract][Full Text] [Related]
32. Further evidence for a functional dorsal-ventral division of the rat striatum: GABAergic involvement in oral movements. Kikuchi de Beltrán K; Koshikawa N; Miwa Y; Kobayashi M; Stephenson JD Eur J Pharmacol; 1993 Aug; 239(1-3):47-54. PubMed ID: 8223913 [TBL] [Abstract][Full Text] [Related]
33. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol. Dunstan R; Jackson DM Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of short- and long-term treatment with neuroleptics on behavioural activity as well as dopamine turnover in striatum. Rastogi RB; Singhal RL; Lapierre YD Gen Pharmacol; 1982; 13(1):35-40. PubMed ID: 6120880 [TBL] [Abstract][Full Text] [Related]
35. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice. Fayle P; Jackson DM; Jenkins OF; Lafferty PA Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755 [TBL] [Abstract][Full Text] [Related]
36. Development of haloperidol-induced dopamine release in the rat striatum using intracerebral dialysis. Walters DE; Chapman CD; Howard SG J Neurochem; 1990 Jan; 54(1):181-6. PubMed ID: 2293609 [TBL] [Abstract][Full Text] [Related]
37. Role of neuroactive steroid allopregnanolone in antipsychotic-like action of olanzapine in rodents. Ugale RR; Hirani K; Morelli M; Chopde CT Neuropsychopharmacology; 2004 Sep; 29(9):1597-609. PubMed ID: 15100702 [TBL] [Abstract][Full Text] [Related]
38. Electrophysiological, biochemical, and behavioral studies of acute haloperidol-induced depolarization block of nigral dopamine neurons. Hollerman JR; Abercrombie ED; Grace AA Neuroscience; 1992; 47(3):589-601. PubMed ID: 1584410 [TBL] [Abstract][Full Text] [Related]
39. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255 [TBL] [Abstract][Full Text] [Related]
40. Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes. Liljequist S; Engel J Psychopharmacology (Berl); 1982; 78(1):71-5. PubMed ID: 6292983 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]